Veronica G Juan

US Patent:

20110305712, Dec 15, 2011

Filed:

Mar 11, 2011

Appl. No.:

13/046498

Inventors:

Yoshiko Akamatsu - Palo Alto CA, US
Veronica Juan - Redwood City CA, US

International Classification:

A61K 39/395
C07K 19/00
A61P 35/00
C12N 15/63
C12N 5/10
C12N 1/19
C07K 16/18
C12N 15/13

US Classification:

4241731, 530324, 5303896, 5303873, 5303917, 4241781, 536 2353, 4353201, 4353432, 4352542

Abstract:

The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.

US Patent:

20130330338, Dec 12, 2013

Filed:

Aug 15, 2013

Appl. No.:

13/968139

Inventors:

Veronica Juan - Redwood City CA, US
Robert B. Dubridge - Belmont CA, US

Assignee:

AbbVie Biotherapeutics Inc. - Redwood City CA

International Classification:

C07K 14/705

US Classification:

4241341, 530324, 5303873, 514 166, 536 235, 536 234, 4353201, 435243, 435325, 435328, 435 693, 514 213, 514 193

Abstract:

The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.

US Patent:

20220251194, Aug 11, 2022

Filed:

Jul 28, 2020

Appl. No.:

17/630586

Inventors:

Veronica JUAN - South San Francisco CA, US
Robert A. KASTELEIN - Porta Valley CA, US
- Rahway NJ, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

C07K 16/28
A61K 45/06
A61P 35/00

Abstract:

Provided herein are treatments of conditions ameliorated by counteracting tumor mediated immune suppression. More specifically, provided herein are anti-PD-1/LAG-3/TIGIT trispecific antibodies, anti-PD-1/LAG3 bispecific antibodies, anti-LAG3 antibodies and antigen-binding fragments. Also provided here are methods and uses of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.

US Patent:

20210032342, Feb 4, 2021

Filed:

Jan 31, 2019

Appl. No.:

16/965616

Inventors:

Veronica Juan - Palo Alto CA, US
Shireen Khan - Castro Valley CA, US
Shaopeng Huang - Shanghai, CN
Hua Ying - Shanghai, CN
- Rahway NJ, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

C07K 16/28
A61K 39/395
A61K 45/06

Abstract:

The present invention relates to anti-PD-1 antibodies and antigen-binding fragments, and use of these antibodies and antigen-binding fragments in the treatment of cancer or infectious disease.

US Patent:

20210017276, Jan 21, 2021

Filed:

Jul 27, 2020

Appl. No.:

16/939883

Inventors:

- Rahway NJ, US
Wolfgang Seghezzi - Mountain View CA, US
Linda Liang - Mountain View CA, US
Veronica Juan - Redwood City CA, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

C07K 16/28
A61P 31/00
A61K 39/395

Abstract:

The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

US Patent:

20190338030, Nov 7, 2019

Filed:

May 1, 2018

Appl. No.:

15/967858

Inventors:

- Belmont CA, US
Veronica Juan - Redwood City CA, US

International Classification:

C07K 16/28

Abstract:

The invention is directed to novel antibody binding compounds specific for the human B7H3 and uses of such compounds for diagnostic and therapeutic purposes.

US Patent:

20190300618, Oct 3, 2019

Filed:

Sep 25, 2017

Appl. No.:

16/336396

Inventors:

- Rahway NJ, US
- Haarlem, NL
Veronica Juan - Redwood City CA, US
Svetlana Sadekova - Mountain View CA, US
Jerelyn Wong - San Jose CA, US
Hans van Eenennaam - Nijmegen, NL
Andrea van Elsas - Oss, NL
Lars Guelen - Nijmegen, NL
Thierry Olivier Fischmann - Scotch Plains NJ, US
Winifred W. Prosise - Ramsey NJ, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
Merck Sharp & Dohme B.V. - Haarlem

International Classification:

C07K 16/28

Abstract:

The present invention relates to anti-CD27 antibodies, as well as use antibodies in the treatment of diseases such as cancer and infectious disease.

US Patent:

20180371083, Dec 27, 2018

Filed:

Aug 9, 2016

Appl. No.:

15/751618

Inventors:

- Rahway NJ, US
Wolfgang Seghezzi - Mountain View CA, US
Linda Liang - Mountain View CA, US
Veronica Juan - Redwood City CA, US

Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ

International Classification:

C07K 16/28
A61K 39/395
A61P 31/00

Abstract:

The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.